Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke
- PMID: 16596121
- DOI: 10.1038/sj.jcbfm.9600311
Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke
Abstract
Bone marrow stromal cells (BMSCs) facilitate functional recovery in rats after stroke when administered acutely (1 day) or subacutely (7 days). In this study, we postponed the time of cell transplantation to 1 month after stroke. Female retired breeder rats were subjected to 2 h of middle cerebral artery occlusion (MCAo). Male BMSCs (3 x 10(6)) or phosphate-buffered saline were administered intravenously, and the animals were killed 3 months later. An additional population of nontreated rats was killed at 1 month after MCAo. Significant recovery of behavior was found in BMSC-treated rats beginning at 1 month after cell injection in the modified neurologic severity score test and the adhesive-removal test compared with control animals (P<0.05). In situ hybridization showed that BMSCs survived and preferentially localized to the ipsilateral hemisphere. Double staining revealed that approximately 13% and 6% Y-chromosome-positive cells expressed the astrocyte marker, glial fibrillary acidic protein, and the neuronal marker, microtubule-associated protein-2, respectively. In addition, BMSC treatment reduced scar thickness, and increased the number of proliferating cells and oligodendrocyte precursor cells along the subventricular zone in the ipsilateral hemisphere. Expression of the chemokine stromal-cell-derived factor-1 (SDF-1) was significantly increased along the ischemic boundary zone compared with the corresponding areas in the contralateral hemisphere at 1 month and 4 months (P<0.01) after stroke. The SDF-1 receptor, CXC-chemokine receptor-4 (CXCR4), was expressed in BMSCs both in vitro and in vivo. Our data show that the time window of BMSC therapy is at least 1 month after stroke; the interaction of SDF-1/CXCR4 may contribute to the trafficking of transplanted BMSCs.
Similar articles
-
One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke.Stroke. 2007 Jul;38(7):2150-6. doi: 10.1161/STROKEAHA.106.481218. Epub 2007 May 24. Stroke. 2007. PMID: 17525391
-
Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat.J Neurosci Res. 2003 Sep 15;73(6):778-86. doi: 10.1002/jnr.10691. J Neurosci Res. 2003. PMID: 12949903
-
Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke.Stem Cells. 2007 Nov;25(11):2777-85. doi: 10.1634/stemcells.2007-0169. Epub 2007 Jul 19. Stem Cells. 2007. PMID: 17641243 Free PMC article.
-
Astrocytic endogenous glial cell derived neurotrophic factor production is enhanced by bone marrow stromal cell transplantation in the ischemic boundary zone after stroke in adult rats.Glia. 2010 Jul;58(9):1074-81. doi: 10.1002/glia.20988. Glia. 2010. PMID: 20468049 Free PMC article.
-
SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model.Brain Res. 2008 Feb 21;1195:104-12. doi: 10.1016/j.brainres.2007.11.068. Epub 2007 Dec 14. Brain Res. 2008. PMID: 18206136
Cited by
-
Mesenchymal stem cells therapy for chronic ischemic stroke-a systematic review.Asian Biomed (Res Rev News). 2024 Oct 31;18(5):194-203. doi: 10.2478/abm-2024-0027. eCollection 2024 Oct. Asian Biomed (Res Rev News). 2024. PMID: 39483715 Free PMC article. Review.
-
Mesenchymal Stromal Cells in Ischemic Brain Injury.Cells. 2022 Mar 17;11(6):1013. doi: 10.3390/cells11061013. Cells. 2022. PMID: 35326464 Free PMC article. Review.
-
Brain repair: cell therapy in stroke.Stem Cells Cloning. 2014 Feb 21;7:31-44. doi: 10.2147/SCCAA.S38003. eCollection 2014. Stem Cells Cloning. 2014. PMID: 24627643 Free PMC article. Review.
-
Systemic infusion of mesenchymal stem cells improves cell-based bone regeneration via upregulation of regulatory T cells.Tissue Eng Part A. 2015 Feb;21(3-4):498-509. doi: 10.1089/ten.TEA.2013.0673. Epub 2015 Jan 19. Tissue Eng Part A. 2015. PMID: 25159486 Free PMC article.
-
Hypoxia/Reoxygenation-Preconditioned Human Bone Marrow-Derived Mesenchymal Stromal Cells Rescue Ischemic Rat Cortical Neurons by Enhancing Trophic Factor Release.Mol Neurobiol. 2015 Aug;52(1):792-803. doi: 10.1007/s12035-014-8912-5. Epub 2014 Oct 8. Mol Neurobiol. 2015. PMID: 25288154
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical